Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Alumis Inc. | 5,896,995 | 5,896,995 | 0 | $129.91M | $165.94M | 45.81% | +$36.03M |
| CG Oncology, Inc.(CGON) | 1,004,050 | 1,079,050 | +75,000 | $67.95M | $76.67M | 21.17% | +$8.71M |
| Disc Medicine, Inc.(IRON) | 374,069 | 374,069 | 0 | $23.92M | $27.36M | 7.55% | +$3.44M |
| Hims & Hers Health, Inc.CL A(HIMS) | 738,151 | 738,151 | 0 | $15.32M | $25.59M | 7.07% | +$10.27M |
| Pharvaris N.V. COM | 194,125 | 664,142 | +470,017 | $5.48M | $22.97M | 6.34% | +$17.48M |
| Eikon Therapeutics, Inc.(EIKN) | 1,318,983 | 1,318,983 | 0 | $13.95M | $17.21M | 4.75% | +$3.26M |
| Odyssey Therapeutics, Inc. | 0 | 713,105 | +713,105 | $0 | $13.34M | 3.68% | +$13.34M |
| Lyell Immunopharma, Inc.(LYEL) | 477,078 | 476,386 | -692 | $9.57M | $6.69M | 1.85% | -$2.88M |
| Nurix Therapeutics, Inc.(NRIX) | 265,000 | 265,000 | 0 | $4.11M | $6.43M | 1.77% | +$2.32M |
| Maze Therapeutics, Inc.(MAZE) | 25,905 | 0 | -25,905 | $773.3K | $0 | — | -$773.3K |